Cerner Capital

Established in 2001, Cerner Capital is a disciplined investment firm headquartered in Atlanta, Georgia. It specializes in early-stage and growth capital investments within the healthcare technology and financial services sectors.

Raymond Payne

Founder and Managing Partner

8 past transactions

Carevive Systems

Series C in 2021
Carevive Systems, Inc. is a healthcare technology company that specializes in enhancing cancer care delivery through its innovative platform. The company offers Carevive PROmpt, a comprehensive software solution designed for treatment planning, patient engagement, symptom management, and survivorship care. This platform includes features such as electronic patient-reported outcomes (ePRO), care coordination tools, and analytics that help oncology practices adapt to value-based care models. Carevive Systems also provides a Risk Stratification model to identify at-risk patients and develops symptom management plans based on clinical data and evidence-based guidelines. Founded in 2013 and based in North Miami, Florida, Carevive Systems aims to improve clinical outcomes and patient experiences by delivering personalized and continuously updated cancer care plans.

Xealth

Venture Round in 2020
Xealth is a digital health technology company that provides a platform enabling clinicians to integrate, prescribe, and monitor digital health tools within electronic health record workflows. The Xealth platform helps care teams select appropriate digital health tools and programs, deliver orders to patients via email or patient portal, and track patient engagement and utilization, at both individual and system levels. The platform supports patient education and connects with online third-party apps and programs, device monitoring, and non-clinical services such as ride-sharing, food delivery, and e-commerce recommendations. Founded in 2016 and based in Seattle, Xealth focuses on scaling healthcare workflows by automating the prescription and monitoring of digital health tools to improve engagement and outcomes.

Carevive Systems

Series C in 2020
Carevive Systems, Inc. is a healthcare technology company that specializes in enhancing cancer care delivery through its innovative platform. The company offers Carevive PROmpt, a comprehensive software solution designed for treatment planning, patient engagement, symptom management, and survivorship care. This platform includes features such as electronic patient-reported outcomes (ePRO), care coordination tools, and analytics that help oncology practices adapt to value-based care models. Carevive Systems also provides a Risk Stratification model to identify at-risk patients and develops symptom management plans based on clinical data and evidence-based guidelines. Founded in 2013 and based in North Miami, Florida, Carevive Systems aims to improve clinical outcomes and patient experiences by delivering personalized and continuously updated cancer care plans.

Voalte

Series D in 2015
Voalte, Inc. is a healthcare technology company that specializes in smartphone software solutions aimed at enhancing caregiver communications within hospitals. Founded in 2008 and based in Sarasota, Florida, Voalte offers a range of products to improve care coordination, including Voalte One, which integrates voice over Internet Protocol (VoIP) calling, alarm notifications, and text messaging. Additionally, the company provides Voalte Me, a texting solution that connects doctors and care team members, Voalte Story for social-based enterprise communication, and Voalte Connect, a mobile device management solution. Voalte's technologies enable healthcare professionals to access electronic medical records and other critical information securely, fostering collaboration among care teams both inside and outside hospital settings. The company operates in multiple locations, including Seattle, Uruguay, Vietnam, New York, and Spain, and functions as a subsidiary of Hill-Rom, Inc. as of April 2019.

Cureatr

Series B in 2015
Cureatr Inc. is a New York-based company that specializes in mobile care coordination solutions for healthcare providers. Founded in 2011, it offers a cloud-based medication management software designed to optimize patient care, particularly focusing on post-discharge medication reconciliation. The platform combines HIPAA-secure text messaging with workflow navigation tools, facilitating communication and coordination among healthcare professionals. Cureatr's software features an inbuilt dashboard that curates and analyzes patients' medication history, enabling providers to respond to real-time events and improve their interactions with patients. By streamlining these processes, Cureatr enhances the overall quality of patient care.

Sotera Wireless

Venture Round in 2014
Sotera Wireless is a medical device company dedicated to developing, marketing, and selling a new generation of comprehensive vital signs monitoring. Its mission is to improve patient safety by empowering clinicians to detect early signs of deterioration in virtually any care setting and enable early intervention and rapid response, all without limiting the patient’s freedom of movement.

Claritas Genomics

Series A in 2013
Claritas Genomics, Inc. is a genetic diagnostic laboratory based in Cambridge, Massachusetts, specializing in testing and research services for pediatric disorders. Founded in 2012, the company is a subsidiary of The Children's Hospital Corporation and operates in partnership with Boston Children's Hospital. Claritas offers a range of services, including clinical exome analysis, single gene sequencing, and various assay analyses. Its laboratory combines advanced genetic testing technologies with expert clinical interpretation provided by specialists in medical genomics. The aim is to simplify the selection of molecular tests and provide clear, reliable reports that communicate complex genetic information effectively, thereby supporting clinicians in making informed medical decisions.

Sotera Wireless

Series D in 2013
Sotera Wireless is a medical device company dedicated to developing, marketing, and selling a new generation of comprehensive vital signs monitoring. Its mission is to improve patient safety by empowering clinicians to detect early signs of deterioration in virtually any care setting and enable early intervention and rapid response, all without limiting the patient’s freedom of movement.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.